[Artificial intelligence-driven drug development against autoimmune diseases]
Med Sci (Paris)
.
2024 May;40(5):414-416.
doi: 10.1051/medsci/2024055.
Epub 2024 May 31.
[Article in French]
Author
Philippe Moingeon
1
Affiliation
1
Institut de recherche Servier, Université Paris-Saclay, Gif-sur-Yvette, France.
PMID:
38819275
DOI:
10.1051/medsci/2024055
No abstract available
Publication types
News
MeSH terms
Artificial Intelligence*
Autoimmune Diseases* / drug therapy
Autoimmune Diseases* / immunology
Drug Development* / methods
Drug Development* / trends
Humans